These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity. Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458 [TBL] [Abstract][Full Text] [Related]
44. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass? Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305 [TBL] [Abstract][Full Text] [Related]
45. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time. Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781 [TBL] [Abstract][Full Text] [Related]
46. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery. Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463 [TBL] [Abstract][Full Text] [Related]
47. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass. Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157 [TBL] [Abstract][Full Text] [Related]
48. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Aldea GS; O'Gara P; Shapira OM; Treanor P; Osman A; Patalis E; Arkin C; Diamond R; Babikian V; Lazar HL; Shemin RJ Ann Thorac Surg; 1998 Feb; 65(2):425-33. PubMed ID: 9485240 [TBL] [Abstract][Full Text] [Related]
49. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508 [TBL] [Abstract][Full Text] [Related]
51. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Brister SJ; Ofosu FA; Buchanan MR Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131 [TBL] [Abstract][Full Text] [Related]
52. Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients. Bernet F; Carrel T; Marbet G; Skarvan K; Stulz P J Card Surg; 1999; 14(2):92-7. PubMed ID: 10709819 [TBL] [Abstract][Full Text] [Related]
53. Monitoring activated clotting time for combined heparin and aprotinin application: an in vitro evaluation of a new aprotinin-insensitive test using SONOCLOT. Ganter MT; Dalbert S; Graves K; Klaghofer R; Zollinger A; Hofer CK Anesth Analg; 2005 Aug; 101(2):308-314. PubMed ID: 16037133 [TBL] [Abstract][Full Text] [Related]
54. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. Dietrich W; Spannagl M; Schramm W; Vogt W; Barankay A; Richter JA J Thorac Cardiovasc Surg; 1991 Oct; 102(4):505-14. PubMed ID: 1833592 [TBL] [Abstract][Full Text] [Related]
55. Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery. Hendrice C; Schmartz D; Pradier O; Coron T; Kucharcezwski C; d'Hollander A; Capel P J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):245-9. PubMed ID: 7545449 [TBL] [Abstract][Full Text] [Related]
56. The plasma supplemented modified activated clotting time for monitoring of heparinization during cardiopulmonary bypass: a pilot investigation. Koster A; Despotis G; Gruendel M; Fischer T; Praus M; Kuppe H; Levy JH Anesth Analg; 2002 Jul; 95(1):26-30, table of contents. PubMed ID: 12088937 [TBL] [Abstract][Full Text] [Related]
57. Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Slaughter TF; Mark JB; El-Moalem H; Hayward KA; Hilton AK; Hodgins LP; Greenberg CS Blood Coagul Fibrinolysis; 2001 Jan; 12(1):25-31. PubMed ID: 11229823 [TBL] [Abstract][Full Text] [Related]
58. Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients. Dietrich W; Braun S; Spannagl M; Richter JA Anesth Analg; 2001 Jan; 92(1):66-71. PubMed ID: 11133602 [TBL] [Abstract][Full Text] [Related]
59. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877 [TBL] [Abstract][Full Text] [Related]
60. Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Lentschener C; Cottin P; Bouaziz H; Mercier FJ; Wolf M; Aljabi Y; Boyer-Neumann C; Benhamou D Anesth Analg; 1999 Sep; 89(3):590-7. PubMed ID: 10475286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]